Novel small molecule activators of β-catenin-mediated signaling pathway: structure–activity relationships of indirubins

Novel small molecule activators of β-catenin-mediated signaling pathway: structure–activity relationships of indirubins Synthesis and biological evaluation of imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyridines as new inhibitors of the Wnt/β-catenin signaling Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists of β-catenin/TCF transcription Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling 5-Bromoindirubin 3′-(O-oxiran-2-ylmethyl)oxime: A long-acting anticancer agent and a suicide inhibitor for epoxide hydrolase Pharmacological properties of indirubin and its derivatives Biophysical Survey of Small-Molecule β-Catenin Inhibitors: A Cautionary Tale Induction of apoptosis by a novel indirubin-5-nitro-3′-monoxime, a CDK inhibitor, in human lung cancer cells Direct targeting of β-catenin: Inhibition of protein–protein interactions for the inactivation of Wnt signaling Synthesis and Antiproliferative Activity of 7-Azaindirubin-3′-oxime, a 7-Aza Isostere of the Natural Indirubin Pharmacophore